This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
219677-82-4
Lisinopril Impurity D
C21H29N3O4
MW = 387.47
(2S)-2-[(3S,8aR)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4- phenylbutanoic Acid (R,S,S-Diketopiperazine)
Technical Data
| C21H29N3O4 | |
|---|---|
| MW = 387.47 | |
| Optical rotation = [α]D20 65.40° | |
| White to off-white solid |
Storage Shipping
| H303 - May be harmful if swallowed | |
|---|---|
| H313 - May be harmful in contact with skin | |
| P280 - Wear protective gloves/protective clothing/eye protection/face protection. | |
| Store at 2-8°C, ship at ambient temperature |
Description
Lisinopril EP Impurity D; (2S)-2-[(3S,8aR)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4- phenylbutanoic Acid (R,S,S-Diketopiperazine); CAS 219677-82-4 is the R,S,S-Diketopiperazine impurity of Lisinopril, an angiotensin-converting enzyme inhibitor class drug used to treat high blood pressure, heart failure, and after heart attacks.